#Latest news with #GLUEWashington Post08-05-2025BusinessWashington PostMonte Rosa Therapeutics: Q1 Earnings SnapshotBOSTON — BOSTON — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported first-quarter profit of $46.9 million. The Boston-based company said it had net income of 57 cents per share. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.
Washington Post08-05-2025BusinessWashington PostMonte Rosa Therapeutics: Q1 Earnings SnapshotBOSTON — BOSTON — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported first-quarter profit of $46.9 million. The Boston-based company said it had net income of 57 cents per share. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.
08-05-2025
